Total Payments
$20,902
2024 Payments
$3,393
Companies
47
Transactions
714
Medicare Patients
2,636
Medicare Billing
$311,024
Payment Breakdown by Category
Food & Beverage$11,156 (53.4%)
Research$4,737 (22.7%)
Consulting$4,068 (19.5%)
Travel$535.56 (2.6%)
Other$213.03 (1.0%)
Education$180.73 (0.9%)
Gifts$11.92 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,156 | 697 | 53.4% |
| Unspecified | $4,737 | 3 | 22.7% |
| Consulting Fee | $4,068 | 3 | 19.5% |
| Travel and Lodging | $535.56 | 2 | 2.6% |
| Entertainment | $213.03 | 2 | 1.0% |
| Education | $180.73 | 6 | 0.9% |
| Gift | $11.92 | 1 | 0.1% |
Payments by Type
General
$16,165
711 transactions
Research
$4,737
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $4,737 | 3 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $3,578 | 3 | $0 (2023) |
| ABBVIE INC. | $2,542 | 174 | $0 (2024) |
| Celgene Corporation | $1,213 | 52 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,104 | 82 | $0 (2024) |
| PFIZER INC. | $932.84 | 59 | $0 (2024) |
| Janssen Biotech, Inc. | $918.78 | 53 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $876.41 | 47 | $0 (2024) |
| Olympus Corporation | $630.00 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $480.60 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,393 | 161 | Olympus Corporation ($630.00) |
| 2023 | $5,794 | 110 | E.R. Squibb & Sons, L.L.C. ($3,578) |
| 2022 | $1,106 | 67 | ABBVIE INC. ($274.32) |
| 2021 | $1,396 | 66 | Eli Lilly and Company ($410.60) |
| 2020 | $801.45 | 40 | AbbVie Inc. ($191.10) |
| 2019 | $1,271 | 69 | AbbVie, Inc. ($287.26) |
| 2018 | $1,496 | 95 | AbbVie, Inc. ($433.34) |
| 2017 | $5,644 | 106 | Eli Lilly and Company ($4,305) |
All Payment Transactions
714 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: GI | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $25.02 | General |
| Category: GI | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/11/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2 MULTICENTER RANDOMIZED PARALLEL-ARM PLACEBO-CONTROLLED STUDY OF LY3074828 IN SUBJECTS WITH ACTIVE CROHNS DISEASE (SERENITY) | Eli Lilly and Company | $4,737 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 681 | 860 | $275,915 | $75,537 |
| 2022 | 13 | 624 | 787 | $276,311 | $74,774 |
| 2021 | 13 | 706 | 864 | $317,813 | $85,734 |
| 2020 | 14 | 625 | 764 | $253,884 | $74,979 |
Total Patients
2,636
Total Services
3,275
Medicare Billing
$311,024
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 100 | 100 | $62,000 | $20,244 | 32.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 116 | 116 | $66,816 | $12,653 | 18.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 48 | 48 | $26,400 | $8,504 | 32.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 115 | 119 | $51,289 | $8,033 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 86 | $13,932 | $7,517 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,660 | $4,726 | 44.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 33 | 37 | $16,206 | $4,439 | 27.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $9,900 | $3,195 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 33 | $3,630 | $2,165 | 59.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 38 | $6,384 | $1,867 | 29.2% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 12 | 12 | $2,412 | $908.52 | 37.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 19 | 58 | $3,596 | $600.30 | 16.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 21 | 61 | $2,196 | $464.21 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 22 | $352.00 | $184.80 | 52.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 18 | 71 | $142.00 | $36.18 | 25.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 88 | 89 | $55,180 | $17,792 | 32.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 136 | 136 | $78,336 | $17,720 | 22.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 46 | 46 | $25,300 | $8,317 | 32.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 124 | 125 | $53,875 | $8,167 | 15.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 65 | $10,530 | $5,794 | 55.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 29 | 29 | $15,950 | $5,369 | 33.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 33 | 36 | $15,768 | $3,970 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $7,280 | $3,086 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 30 | $3,300 | $1,815 | 55.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 12 | 34 | $5,712 | $1,792 | 31.4% |
About Dr. James Dimitroff, MD
Dr. James Dimitroff, MD is a Gastroenterology healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376632018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Dimitroff, MD has received a total of $20,902 in payments from pharmaceutical and medical device companies, with $3,393 received in 2024. These payments were reported across 714 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($11,156).
As a Medicare-enrolled provider, Dimitroff has provided services to 2,636 Medicare beneficiaries, totaling 3,275 services with total Medicare billing of $311,024. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Saint Peters, MO
- Active Since 10/12/2006
- Last Updated 09/17/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1376632018
Products in Payments
- ZEPOSIA (Drug) $4,791
- XELJANZ (Drug) $827.66
- STELARA (Biological) $785.01
- XIFAXAN (Drug) $667.53
- ENTYVIO (Biological) $652.07
- Single Use Repositionable Clip (Device) $630.00
- RINVOQ (Biological) $561.83
- Humira (Biological) $463.08
- DUPIXENT (Biological) $432.72
- HUMIRA (Biological) $398.11
- LINZESS (Drug) $364.34
- Alinia Tablets 500mg 30 count bottle (Drug) $362.11
- ZENPEP (Drug) $288.84
- Amitiza (Drug) $287.86
- MAVYRET (Drug) $199.61
- Linzess (Drug) $196.46
- Mavyret (Drug) $189.23
- Entyvio (Biological) $182.27
- Cimzia (Drug) $172.94
- CREON (Drug) $153.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Saint Peters
Eldad Bialecki, M.d, M.D
Gastroenterology — Payments: $21,349
Gastroenterology $21,349
Richard Geisman, M.d, M.D
Gastroenterology — Payments: $3,923
Gastroenterology $3,923
Robert Cusworth, Md, MD
Gastroenterology — Payments: $211.20
Gastroenterology $211.20
Harry Burack, Md, MD
Gastroenterology — Payments: $14.64
Gastroenterology $14.64